Form 4 for ENGN enGene Therapeutics Inc.
Accepted 2024-04-22 00:00:00 ET · period of report 2024-04-18 · accession 0000950142-24-001171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-04-22 | 2024-04-18+ | ENGN | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% | S - Sale | $15.00 | -52.5K | 3.08M | -2% | -$788.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2024-04-19 | S | D | 100 | $15.00 | 3,084,007 | D | — | — | |
| 2 | Common | Common shares | 2024-04-22 | S | D | 47,854 | $15.00 | 3,036,153 | D | — | — | |
| 3 | Common | Common shares | 2024-04-18 | S | D | 4,575 | $15.01 | 3,084,107 | D | — | — |